Index and reference standard tests used in studies of heart-type fatty acid-binding protein
| Study | Index test analyser | Threshold (μg/l) | Reference test assay and timing | Reference Tn threshold (μg/l) | MI prevalence in sample (%) |
| Body 201112 | Alere fluorescence immunoassay | 58 | Roche elecsys TnT at least 12 h after symptom onset | 0.01 | 18% |
| Cete 201013 | CardioDetect | 6.2 | TnT, assay not reported, at 6 h | 0.1 | 33% |
| Charpentier 201014 | CardioDetect | 7 | Advia Centaur TnI system at 6 h | 0.1 | 15% |
| Di Serio 200515 | Randox evidence investigator | 6.4 | Not specified | Not specified | 53% |
| Ecollan 200716 | CardioDetect | 7 | Stratus CS, Dade Behring TnI test at anytime point over 24 h | 0.07 | 51% |
| Garcia-Valdecasas 201117 | Dainippon pharmaceutical ELISA | 6.2 | Dade dimension TnI, timing not stated | 0.6 | 39% |
| Haltern 201018 | HyCult biotechnology ELISA | 7 | Roche Elecsys TnT at 12 h | 0.03 | 33% |
| Hjortshoj 201019 | HyCult biotechnology ELISA | 6.0 | Roche Elecsys TnT after 6–9 h, and 12–24 h | 0.03 | 33% |
| Ilva 200920 | Innotrac Aio! immunoanalyzer | 10.4 | Abbott architect STAT TnI up to 24 h | 0.032 | 46% |
| Lefebrve 200721 | CardioDetect | 6.2 | Dade Behring RxL TnI and Siemens centaur TnI | 0.14 and 0.33 | 48% |
| Li 201022 | Wuhan easy diagnosis biomedicine Co | 7 | TnT, assay not specified, at 12 h | 0.1 | 50% |
| Liao 200923 | CardioDetect | 7 | Not specified | 0.5 | 73% |
| Mad 200724 | CardioDetect | 7 | TnT, assay not specified, at 10–12 h | 0.04 | 39% |
| McCann 200825 | HyCult biotechnology ELISA | 1.2 | Roche Elecsys TnT at 12 h | 0.03 | 48% |
| Mion 200726 | Evidence cardiac panel | 6.02 | Dimension RxL TnI, timing not stated | 0.15 | 32% |
| Naroo 200927 | CardioDetect | 7 | TN, assay not specified, at 6–12 h | 1 | 13% |
| Valle 200728 | CardioDetect | 7 | TnT, assay not specified, at 6–12 h | Not stated | 35% |
MI, myocardial infarction; TnT, troponin T.